The Discounted Cash Flow (DCF) valuation of Johnson & Johnson (JNJ) is 160.41 USD. With the latest stock price at 156.66 USD, the upside of Johnson & Johnson based on DCF is 2.4%.
Based on the latest price of 156.66 USD and our DCF valuation, Johnson & Johnson (JNJ) is a buy. buying JNJ stocks now will result in a potential gain of 2.4%.
| Range | Selected | |
| WACC / Discount Rate | 5.8% - 7.7% | 6.8% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 105.85 - 330.57 | 160.41 |
| Upside | -32.4% - 111.0% | 2.4% |